NCT01309113View on ClinicalTrials.gov

Dose-dependent Effects of VAC BNO 1095 on Cyclic Mastodynia and Premenstrual Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

191

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

November 30, 2012

Conditions
Cyclic MastodyniaPremenstrual Syndrome
Interventions
DRUG

VAC BNO 1095 film coated tablets

3 dosages: Placebo, 10 mg of VAC BNO 1095 once daily in the morning, 10 mg of VAC BNO 1095 twice daily in the morning and in the evening

Trial Locations (1)

771 30

Gynekologicko-porodnická ambulance, Olomouc

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY